After being all-but written off a year ago, AstraZeneca’s anifrolumab has been reborn with new data that suggest it could help to end a drought in treatments for autoimmune disease systemic ...
Saphnelo (anifrolumab) is the first biologic drug for SLE to be approved in Europe that is not restricted to patients with a high degree of disease activity, according to AZ, which also notes it ...
Streuhaar oder Schütthaar hat sich in den vergangenen Jahren immer stärker als kurzfristiges Mittel gegen lichter werdendes Haar etabliert. Eine volle Haarpracht steht für viele Menschen für ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback